Digital WuXi Global Forum 2024


Dear colleagues and friends,


Following the resounding success of the 12th annual WuXi Global Forum during JPM2024, we're bringing the experience online for colleagues around the world unable to attend in person. Join us for the Digital WuXi Global Forum 2024 on Jan 31, to be premiered at 7:00-11:30 AM and 7:00-11:30 PM PST respectively.


This year's theme, B.O.L.D., focuses on Breaking Barriers, Opening New Horizons, Leading Next Generation, and Delivering for Patients. We will delve deep into what matters most to patients. 


Thank you to our distinguished speakers, supportive partners, and thousands of attendees who made our in-person Forum a success.




07:00 AM - 07:05 AM Welcome and Opening Remarks

Hui Cai, Program Chair and Vice President, WuXi AppTec

Minzhang Chen, Co-CEO, WuXi AppTec


07:05 AM - 07:50 AM State of Innovation 2024

Amy Abernethy, CMO & President, Product Development, Verily

Donald Ingber, Founding Director & Chaired Professor, Wyss Institute at Harvard University

Mathai Mammen, CEO & Chairman, FogPharma

John Maraganore, CEO, JMM Innovations

Søren Møller, Managing Partner, Seed Investments, Novo Holdings

Session Leader: Christoph Westphal, Co-Founder & General Partner, Longwood Fund


Spotlight on B.O.L.D.

07:50 AM - 08:25 AM Breaking Barriers. Leaping Forward.

Robert Gabbay, CSO & CMO, American Diabetes Association

Karen Knudsen, CEO, American Cancer Society and ACS CAN; Professor, Sidney Kimmel Cancer Center at Jefferson Health

Joseph Wu, President, American Heart Association; Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences

Session Leader: Margo Georgiadis, Co-Founder & CEO, Montai Health; CEO-Partner, Flagship Pioneering


08:25 AM - 09:10 AM Opening Up New Horizons: Spotlight on Cancer

Philip Kantoff, Co-Founder & CEO, Convergent Therapeutics

Samir Khleif, Founder & CEO, Georgiamune

Crystal Mackall, Professor of Pediatrics and Medicine, Stanford University; Director, Stanford Center for Cancer Cell Therapy

Briggs Morrison, CEO, Crossbow Therapeutics

Session Leader: Karen Tkach Tuzman, Director, Biopharma Intelligence, BioCentury


09:10 AM - 09:55 AM Leading Transformation: The Next Wave Therapeutics

Wolfram Carius, EVP Pharmaceuticals, Bayer

Abraham Ceesay, CEO, Rapport Therapeutics

Pavan Cheruvu, President & CEO, Bitterroot Bio

Giuseppe “Pino” Ciaramella, Co-Founder & CEO, Orbital Therapeutics; President, Beam Therapeutics

Kevin Forrest, Co-Founder, President & CEO, Kate Therapeutics

Amber Salzman, CEO, Epic Bio

Session Leader: Edward Hu, Vice Chairman, WuXi AppTec; CEO, WuXi Advanced Therapies


09:55 AM - 10:40 AM Delivering on Future Platform Solutions

Miles Congreve, CSO, Isomorphic Labs

Evan Feinberg, Co-Founder & CEO, Genesis Therapeutics

Nevan Krogan, Co-Founder & President, Rezo Therapeutics; Professor, Cellular and Molecular Pharmacology, UCSF; Investigator, J. David Gladstone Institutes

Ann Lee-Karlon, President & CEO, EpiBiologics

Sabrina Yang, Co-Founder & CIO, Empress Therapeutics; Principal, Flagship Pioneering

Session Leader: John Carroll, Editor & Founder, Endpoints News


10:40 AM - 11:30 AM Scaling Breakthroughs Forward

Vineeta Agarwala, General Partner, Andreessen Horowitz (a16z) Bio + Health

Alexis Borisy, Co-Founder & Chairman, Curie.Bio

Laura Furmanski, Partner, Patient Square Capital

Rogier Rooswinkel, General Partner, Forbion

Tim Shannon, General Partner, Canaan

John Wesley, Investment Director, NVentures

Session Leader: Steve Yang, Co-CEO, WuXi AppTec


Please click here for the speaker bios.